NEW YORK (GenomeWeb News) — US patent regulators have put Applied Biosystems at a big disadvantage in an important sequencing technology issue after they recently named a key licensing partner the junior party in a patent-interference review triggered after a 25-year-old patent application filed by Enzo Biochem was approved.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.

Sponsored by

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.